Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass. [electronic resource]
- Journal of musculoskeletal & neuronal interactions Mar 2011
- 34-45 p. digital
Aged Alendronate--administration & dosage Bone Density--drug effects Bone Density Conservation Agents--administration & dosage Bone Resorption--drug therapy Bone and Bones--drug effects Double-Blind Method Drug Therapy, Combination Female Humans Hydroxycholecalciferols--administration & dosage Osteoporosis, Postmenopausal--diagnostic imaging Radiography